International Conference for Corporate Communication and Public Relations “European Communication Summit 2012”, organized yearly by the European Association of Communication Directors, was held in Brussels on the 5-th and 6-th of July 2012.

The collective project „I am Proud of my Parents' Work” carried off the prize at the ceremony of the traditional Annual Human Resources Awards, held on 20.01.2016 at Rainbow Plaza, Sofia. The project of the Bulgarian Global CompactNetworkgained distinction as the best 2015 project for integrating education into business. This award was for HR project for effective and operative interaction between business and education. This is the third year of the project, each issue being „improved” by new ideas and programs.

A joint meeting of the Spanish Generic Medicines Association (AESEG) and European Generic and Biosimilar Medicines Association (EGA), whose member is the Bulgarian Generic Pharmaceutical Association (BGPharmA), took place on January 19, 2016 in Barcelona. Highlighting industry’s commitment to increase patients’ access to high-quality medicines, both associations confirmed their commitment to join their efforts and to provide the Spanish market with access to generic medicines.

Mr. Svilen Neykov, Minister of Physical Education and Sports and Ms. Catheirne Barber, Deputy Head of Mission at the UK Embassy in Bulgaria, gave a start to the ninth edition of the Olympiad of business leaders organised by the Bulgarian Business Leaders Forum. A month before the Olympic Games in London, the sporting spirit of the representatives of Bulgarian business, the Olympic principle of the importance of participation and the numerous raffle prizes contributed to the good mood of all those present on the 30th June 2012.

On 28.01.2016, the European Generic and Biosimilar Medicines Association (EGA), a member of which is the Bulgarian Generic Pharmaceutical Association (BGPharmA), held the 15th Regulatory and Scientific Affairs Conference where representatives of 61 regulators from 25 countries made progress in improving the generic and biosimilar regulatory landscape for patient needs.